Reteplase (trade names Retavase Rapilysin) is a thrombolytic drug used to treat heart attacks by breaking up the clots that cause them. Reteplase is a recombinant non-glycosylated form of human tissue plasminogen activator which has been modified to contain 357 of the 527 amino acids of the original protein.
This page contains content from the copyrighted Wikipedia article "Reteplase"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.